Abstract:Understanding of the molecular mechanism and biological implication underlying the difference in binding of substrate peptides and small-molecule inhibitors to multidrug-resistant mutants of HIV-1 protease would help to develop new anti-HIV agents combating drug resistance. Here, an integration of rigorous quantum mechanics/molecular mechanics (QM/MM) analysis and empirical Poisson–Boltzmann/surface area (PB/SA) model is described to investigate the structural basis and energetic property of wild-type HIV-1 protease and its mutants in recognizing and binding with a wide variety of ligands, including the peptides derived from its cognate cleavage sites and the cleavage site variants as well as a number of FDA-approved protease inhibitors, attempting to explain why is substrate binding unsusceptible to most observed HIV-1 protease mutations. A preliminary test study demonstrates that the combined QM/MM–PB/SA scheme is able to effectively reproduce the relative ligand binding energy changes upon protease single- and double-mutations, albeit the absolute values appear to be different significantly between the calculated and experimental results. With the QM/MM–PB/SA calculations a complete mutation energy map of HIV-1 protease–ligand interactions is created, which unravels distinct affinity pictures of wild-type substrates, substrate variants and, particularly, the protease inhibitors bound to HIV-1 protease mutants, suggesting that, on the one hand, the evaluation pressure under anti-HIV chemotherapies addresses site-directed protease mutations that impair and undermine the intermolecular interactions specific to inhibitors but not substrates; on the other hand, co-evaluation of protease and its substrate peptides provides a more effective mechanism to avoid therapeutic surveillance. Further, nonbonded interaction analysis and computational alanine scanning reveal 12 key residues that is critical for substrate binding, from which the Asn25, Gly27, Ala28, Asp29 and Pro81 are identified that have not yet been found to cause drug resistance and hence would be the promising sites targeted by new protease inhibitors.

Studies on the Specificity of Hiv Protease - an Application of Markov-Chain Theory

An Alternate-Subsite-Coupled Model for Predicting Hiv Protease Cleavage Sites in Proteins

HIV‐1 Protease Cleavage Site Prediction Based on Amino Acid Property

A Vector Projection Approach to Predicting Hiv Protease Cleavage Sites in Proteins

HIV-1 Protease Cleavage Site Prediction Based on Two-Stage Feature Selection Method

In Silico Prediction of Mutant HIV-1 Proteases Cleaving a Target Sequence

Incorporating the Coevolving Information of Substrates in Predicting HIV-1 Protease Cleavage Sites

A New Sequence Representation As Applied in Better Specificity Elucidation for Human Immunodeficiency Virus Type 1 Protease

Predicting Human Immunodeficiency Virus Protease Cleavage Sites in Nonlinear Projection Space

HIVcleave: a web-server for predicting human immunodeficiency virus protease cleavage sites in proteins.

Screening Novel HIV-1 Protease Inhibitors Based on the Substrate Envelope Hypothesis

Prediction of HIV-1 protease cleavage site from octapeptide sequence information using selected classifiers and hybrid descriptors

Why is Substrate Peptide Binding Unsusceptible to Multidrug-Resistant Mutations in HIV-1 Protease? A Structural and Energetic Analysis

Procleave: Predicting Protease-specific Substrate Cleavage Sites by Combining Sequence and Structural Information

Modeling Studies of Peptide Inhibitors for the HIV Protease

Proteochemometric Modeling Of The Bioactivity Spectra Of Hiv-1 Protease Inhibitors By Introducing Protein-Ligand Interaction Fingerprint

Studies on the Prediction of Selective Cleavage Sites and Cleavage Profile of Proteasome Using VHSE Amino Acid Descriptor

Revealing Favorable and Unfavorable Residues in Cooperative Positions in Protease Cleavage Sites.

Crucial stages of protein folding through a solvable model: predicting target sites for enzyme-inhibiting drugs

Comprehensive protease specificity profiling

The Probabilistic Prediction of Protein Cleavage Site for Tryptic Peptides Based on Markov Chain